Edition:
United States

Immune Design Corp (IMDZ.OQ)

IMDZ.OQ on NASDAQ Stock Exchange Global Market

3.65USD
4:00pm EDT
Change (% chg)

$-0.22 (-5.81%)
Prev Close
$3.88
Open
$3.85
Day's High
$3.85
Day's Low
$3.65
Volume
24,531
Avg. Vol
76,865
52-wk High
$13.00
52-wk Low
$2.80

Select another date:

Wed, Mar 14 2018

BRIEF-Immune Design Reports Q4 Loss Per Share $0.29

* IMMUNE DESIGN REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

BRIEF-Immune Design Reports Data Update For Lead Immunotherapy Programs

* IMMUNE DESIGN REPORTS DATA UPDATE FOR LEAD IMMUNOTHERAPY PROGRAMS: IMPROVEMENT IN SURVIVAL FOR CMB305 MONOTHERAPY IN SARCOMA AND INCREASED OBJECTIVE RESPONSES FOR G100/PEMBROLIZUMAB COMBINATION IN FOLLICULAR LYMPHOMA

BRIEF-Immune Design To Report Q4 And Year End 2017 Financial Results And Provide Corporate Update

* IMMUNE DESIGN TO REPORT FOURTH QUARTER AND YEAR END 2017 FINANCIAL RESULTS AND PROVIDE CORPORATE UPDATE Source text for Eikon: Further company coverage:

BRIEF-Ecor1 Capital reports 7.4% passive stake in Immune Design

* Ecor1 Capital Llc reports 7.4% passive stake in Immune Design Corp as of Oct 25 - SEC filing‍​ Source text: (http://bit.ly/2zkI4Ki) Further company coverage:

BRIEF-Immune Design reports Q3 loss per share of $0.52

* IMMUNE DESIGN REPORTS THIRD QUARTER 2017 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

BRIEF-Immune Design prices offering of 19.5 million shares at $4.10 per share​

* Immune Design prices $80.0 million public offering of common stock

BRIEF-Immune Design proposes public offering of common stock

* Immune Design announces proposed public offering of common stock

Select another date: